OBJECTIVES: Unhealthy behaviors are responsible for most chronic disease, ample healthcare costs, and around 40% of deaths. This study assessed patient satisfaction and behavioral outcomes for a program that enables healthcare settings to deliver evidence-based, cost-saving behavioral screening and intervention (BSI) services, as recommended by the US Preventive Services Task Force and others. STUDY DESIGN: Pre-post program evaluation. METHODS: Thirty-one diverse primary care clinics and 2 other sites participated. Over 110,000 patients completed multibehavioral screening questionnaires. Those with positive alcohol or drug screens met with dedicated, on-site health educators for further assessment, and then received either reinforcement, brief intervention, or referral. Over 300 patients completed satisfaction questionnaires during year 3 of the program. A pseudo-randomly selected group of 675 patients participated in a 6-month follow-up telephone interview. In addition, for a short time in a pilot project at 3 clinics, 29 patients received depression screening, collaborative care, and behavioral activation, and 22 completed a 3-month follow-up telephone interview. RESULTS: Mean patient satisfaction scores for all services exceeded 4.2 on a 5-point scale. Over 6 months, binge drinking episodes declined by over 20% for most subgroups. Recent marijuana use decreased by 15%. Depression symptom scores decreased by 55%. CONCLUSIONS: With intensive training and ongoing support, cost-efficient paraprofessionals can deliver effective alcohol, drug, and depression screening and intervention services in busy healthcare settings. The approach holds promise for systematically addressing on a population-wide basis a variety of important behavioral health determinants and reducing related healthcare costs.
OBJECTIVES: Unhealthy behaviors are responsible for most chronic disease, ample healthcare costs, and around 40% of deaths. This study assessed patient satisfaction and behavioral outcomes for a program that enables healthcare settings to deliver evidence-based, cost-saving behavioral screening and intervention (BSI) services, as recommended by the US Preventive Services Task Force and others. STUDY DESIGN: Pre-post program evaluation. METHODS: Thirty-one diverse primary care clinics and 2 other sites participated. Over 110,000 patients completed multibehavioral screening questionnaires. Those with positive alcohol or drug screens met with dedicated, on-site health educators for further assessment, and then received either reinforcement, brief intervention, or referral. Over 300 patients completed satisfaction questionnaires during year 3 of the program. A pseudo-randomly selected group of 675 patients participated in a 6-month follow-up telephone interview. In addition, for a short time in a pilot project at 3 clinics, 29 patients received depression screening, collaborative care, and behavioral activation, and 22 completed a 3-month follow-up telephone interview. RESULTS: Mean patient satisfaction scores for all services exceeded 4.2 on a 5-point scale. Over 6 months, binge drinking episodes declined by over 20% for most subgroups. Recent marijuana use decreased by 15%. Depression symptom scores decreased by 55%. CONCLUSIONS: With intensive training and ongoing support, cost-efficient paraprofessionals can deliver effective alcohol, drug, and depression screening and intervention services in busy healthcare settings. The approach holds promise for systematically addressing on a population-wide basis a variety of important behavioral health determinants and reducing related healthcare costs.
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: Paul E Greenberg; Ronald C Kessler; Howard G Birnbaum; Stephanie A Leong; Sarah W Lowe; Patricia A Berglund; Patricia K Corey-Lisle Journal: J Clin Psychiatry Date: 2003-12 Impact factor: 4.384
Authors: Heather M Pierson; Steven C Hayes; Elizabeth V Gifford; Nancy Roget; Michele Padilla; Richard Bissett; Kristen Berry; Barbara Kohlenberg; Robert Rhode; Gary Fisher Journal: J Subst Abuse Treat Date: 2006-10-13
Authors: Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg Journal: Am J Prev Med Date: 2006-07 Impact factor: 5.043
Authors: Anilkrishna B Thota; Theresa Ann Sipe; Guthrie J Byard; Carlos S Zometa; Robert A Hahn; Lela R McKnight-Eily; Daniel P Chapman; Ana F Abraido-Lanza; Jane L Pearson; Clinton W Anderson; Alan J Gelenberg; Kevin D Hennessy; Farifteh F Duffy; Mary E Vernon-Smiley; Donald E Nease; Samantha P Williams Journal: Am J Prev Med Date: 2012-05 Impact factor: 5.043
Authors: Jason Paltzer; Richard L Brown; Marguerite Burns; D Paul Moberg; John Mullahy; Ajay K Sethi; David Weimer Journal: J Behav Health Serv Res Date: 2017-01 Impact factor: 1.505
Authors: Mayank Sardana; Yuanyuan Tang; Jared W Magnani; Ira S Ockene; Jeroan J Allison; Suzanne V Arnold; Phillip G Jones; Thomas M Maddox; Salim S Virani; David D McManus Journal: J Am Heart Assoc Date: 2019-06-28 Impact factor: 5.501